You have 9 free searches left this month | for more free features.

Condition

Sickle Cell Disease (3)

Polycythemia Vera (1)

Overall Status

Recruiting (4)

Sign in for free

Phase

phase 2 (2)

phase 3 (1)

Sponsor

ADDMEDICA SASA (3)

University of Birmingham (1)

Collaborator

International Clinical Trials Association (1)

MPN Voice (1)

National Cancer Institute, France (1)

Novartis (1)

Intervention

hydroxycarbamide (4)

interferon-alpha (1)

placebo oral tablet (1)

ruxolitinib (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (3)

Observational (1)

hydroxycarbamide

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Sickle Cell Disease Trial in Créteil, Paris (Hydroxycarbamide)

Recruiting

Sickle Cell Disease

Hydroxycarbamide

Créteil, France
+2 more

Jul 21, 2022

Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

Recruiting

Polycythemia Vera

Ruxolitinib
+2 more

London, United Kingdom
+1 more

Nov 29, 2021

Sickle Cell Disease Trial in Worldwide (Hydroxycarbamide, Placebo Oral Tablet)

Recruiting

Sickle Cell Disease

Hydroxycarbamide
Placebo Oral Tablet

Abidjan, Côte D'Ivoire
+20 more

Jan 26, 2023

ESCORT-HU Extension: European Sickle Cell Disease Cohort -

Recruiting

Sickle Cell Disease

Hydroxycarbamide

Amiens, France
+78 more

Mar 24, 2022